{
  "id": 17040739,
  "title": "RFK Jr. eases access to unproven peptides despite opposition from FDA scientists",
  "url": "https://urgent.news/2026/10/29/rfk-jr-eases-access-to-unproven-peptides-despite-opposition-from-fda",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-29T09:18:35.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-rfk-jr-eases-access-unproven.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "MedPage Today",
        "title": "RFK Jr. Eases Access to Unproven Peptides Despite Opposition From FDA Scientists",
        "url": "https://urgent.news/2026/10/28/rfk-jr-eases-access-to-unproven-peptides-despite-opposition-from-fda",
        "published": "2026-10-28T20:48:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}